NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), to be renamed Stablecoin Development Corporation (NYSE American: SDEV), is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's common stock is expected to begin trading on the NYSE American under the ticker symbol SDEV on April 3, 2026. In 2026, the Company completed a comprehensive realignment of its business, adopting a capital allocation approach focused on acquiring and holding economically productive digital assets that enable participation in open, decentralized financial networks. The Company's core business consists of the accumulation, holding, and deployment of operating digital assets for use within blockchain-based networks to support protocol-level services, including staking, governance participation, and related activities. The Company's initial focus is SKY, the protocol token of the decentralized Sky Protocol. In January 2026, the Company completed a ~$134 million private placement with R01 Fund LP, Framework Ventures, Tether Investments, and Sky Frontier Foundation, consisting of cash, stablecoins, and SKY tokens. The Company continues to deploy capital toward the acquisition of additional SKY tokens on the open market. Headquartered in Emeryville, California. Committed to prudent governance, regulatory compliance, and long-term shareholder value creation. For more information, visit www.novabay.com.
我們正在追蹤 NovaBay Pharmaceuticals 的市場擴張
NovaBay Pharmaceuticals 的國際擴張與競爭對手的比較
NovaBay Pharmaceuticals你長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
 NovaBay Pharmaceuticals你 | 0 | 0 | — | 0 | 0 |
目前並無招聘
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
無進行中的廣告活動
註冊以追蹤此公司，並在發生變化時第一時間獲得提醒。
解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 NovaBay Pharmaceuticals 業務、市場及增長訊號的快速解答。
